drugset / Trial / NCT01602562
Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation Patients
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate the preventive efficacy for HSV infection and safety of valaciclovir (VACV) in the adult and pediatric HSCT patients.
Timeline
- Start
- 2012-05-07
- Primary completion
- 2013-05-01
- Completion
- 2013-05-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Valaciclovir | Unknown | 25 mg/kg | Oral |
| Subject | Valaciclovir | Unknown | 500 mg | Oral |